clinical 3,109 words KG: Tricaprilin Phase 3 ALTER-AD Study (NCT05809908)
Contents

Tricaprilin Phase 3 ALTER-AD Study (NCT05809908)

No AI portrait yet

Knowledge Graph

Related Hypotheses (28)

Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Brain Insulin Resistance with Glucose Transporter Dysfunctio
Score: 0.60
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76

Related Analyses (6)

Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed

Related Experiments (5)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90
Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40
Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40

Knowledge Graph (2 edges)

Tricaprilin Phase 3 ALTER-AD Study (NCT05809908) references GFAP
Tricaprilin Phase 3 ALTER-AD Study (NCT05809908) references GLUT3

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)